wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34581511-03E9974A-F046-4F32-A986-9C23F999E252
Q34581511-03E9974A-F046-4F32-A986-9C23F999E252
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34581511-03E9974A-F046-4F32-A986-9C23F999E252
Study on requirements of bioequivalence for registration of pharmaceutical products in USA, Europe and Canada
P2860
Q34581511-03E9974A-F046-4F32-A986-9C23F999E252
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34581511-03E9974A-F046-4F32-A986-9C23F999E252
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be84da5585d9e91f46ee4a099ca1c4e8e1bde9af
P2860
Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone pr